Rhabdomyolysis associated with bupropion use as a smoking cessation adjunct: Review of the literature

Military Medicine

Volumn 173, Issue 10, 2008, Pages 1042-1043

  Miladi, Anis ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE PATCH;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANXIETY DISORDER; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CHEST TIGHTNESS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISTRESS SYNDROME; DRUG DOSE INCREASE; DRUG EFFECT; DRUG USE; DRUG WITHDRAWAL; DYSPNEA; FOLLOW UP; HUMAN; INSOMNIA; MALE; RHABDOMYOLYSIS; RISK FACTOR; SIDE EFFECT; SMOKING CESSATION; SOLDIER; SUSTAINED RELEASE FORMULATION; SYMPTOM; THORAX PAIN; TOBACCO DEPENDENCE;

EID: 53849111599     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.173.10.1042     Document Type: Article

References (5)

1. Bobe F, Buil ME, Palacios L: Rhabdomyolysis connected with the use of bupropion: a possible complication of medical treatment for smoking cessation. Scand J Prim Health Care 2004; 22: 191-2.
2. David D, Esquenazi J: Rhabdomyolysis associated with bupropion treatment [letter]. J Clin Psychopharmacol 1999; 19: 185-6.
3. Iskandar SB, Brahmbhatt VR. al Hasan MA, Hudgins L: Muscle injury associated with bupropion therapy. Tenn Med 2003; 96: 471-2.
4. Ward MM: Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med 1988; 148: 1553-7.
5. Aubin HJ: Tolerability and safety of sustained-release bupropion in the management of smoking cessation. Drugs 2002; 62(Suppl 2): 45-52.